Your missing something here Putt, forget the attack comments. Any CR is a dilution, what was interesting was the CR was never enough to warrant insto involvement and hence back at square 1 with existing copping 6% dilution and no real insto involvement. Grab for cash!
I think it’s reasonable to assume 100-1 is silly, and please remember this is all JIMO, at 1b SOI the company can expect Insto investment. A large investor cannot take a stake in Renergen at current prices and SOI.
So assume, Things remain as they are with a Chinese investment of 13.5% and free float of 47%, equity is going to be very hard to aquire. Maybe not in JSE but they are along way behind the times market wise.
So how does one aquire a % when 80k of shares up for sale?
I am 2 years behind my expectations of ASX300 for these simple reasons.
Too answer your last question, I invested very early in the company, 2019 in fact. Holding account and trading account. Many of my associates are invested.
Always been bullish, ask Chaya etc. I just won’t accept fanfare without questioning.
Fanfare #1 The company is unproven.
Take care Putt.
- Forums
- ASX - By Stock
- RLT
- RLT CHART
RLT CHART, page-1146
-
-
- There are more pages in this discussion • 2,018 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RLT (ASX) to my watchlist
(20min delay)
|
|||||
Last
84.0¢ |
Change
-0.010(1.18%) |
Mkt cap ! $25.47M |
Open | High | Low | Value | Volume |
85.0¢ | 85.0¢ | 84.0¢ | $3.223K | 3.803K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 81.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
84.0¢ | 235 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.825 |
1 | 1000 | 0.800 |
1 | 25000 | 0.795 |
2 | 6800 | 0.750 |
1 | 15000 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.840 | 400 | 1 |
0.850 | 7698 | 1 |
0.875 | 1261 | 1 |
0.895 | 2500 | 2 |
0.970 | 70710 | 2 |
Last trade - 15.51pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
RLT (ASX) Chart |